Boston Immune Technologies & Therapeutics (BITT) is a Boston-based biopharmaceutical company developing immune-based approaches for the treatment of cancer and infectious diseases.  For more information on our oncology and infectious disease programs, click on the links below:

Oncology

Infectious disease